Skin colour changes in psoriasis responding to treatment with betamethasone-17-valerate under occlusion.
D001623:Betamethasone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009779:Occlusive Dressings; D010858:Pigmentation / Q000187:drug effects*; D011565:Psoriasis / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects; D013056:Spectrophotometry, Ultraviolet; D014631:Valerates
D014631:Valerates; D001623:Betamethasone